Intervention Review

You have free access to this content

Mycobacterium vaccae immunotherapy for treating tuberculosis

  1. Guy de Bruyn1,*,
  2. Paul Garner2

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 20 JAN 2010

Assessed as up-to-date: 4 OCT 2002

DOI: 10.1002/14651858.CD001166

How to Cite

de Bruyn G, Garner P. Mycobacterium vaccae immunotherapy for treating tuberculosis. Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD001166. DOI: 10.1002/14651858.CD001166.

Author Information

  1. 1

    Wits Health Consortium, Perinatal HIV Research Unit, Johannesburg, Guateng, South Africa

  2. 2

    Liverpool School of Tropical Medicine, International Health Group, Liverpool, Merseyside, UK

*Guy de Bruyn, Perinatal HIV Research Unit, Wits Health Consortium, PO Box 114, Diepkloof, Johannesburg, Guateng, 1864, South Africa. debruyng@phru.co.za.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 20 JAN 2010

SEARCH

[Analysis 1.1]
Analysis 1.1. Comparison 1 Mycobacterium vaccae immunotherapy versus placebo, Outcome 1 Death.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Mycobacterium vaccae immunotherapy versus placebo, Outcome 2 Sputum smear negative by 2 months.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Mycobacterium vaccae immunotherapy versus placebo, Outcome 3 Sputum culture negative at 2 months.
[Analysis 1.4]
Analysis 1.4. Comparison 1 Mycobacterium vaccae immunotherapy versus placebo, Outcome 4 Sputum culture negative at completion of chemotherapy.
[Analysis 1.5]
Analysis 1.5. Comparison 1 Mycobacterium vaccae immunotherapy versus placebo, Outcome 5 Number with cavities present.
[Analysis 1.6]
Analysis 1.6. Comparison 1 Mycobacterium vaccae immunotherapy versus placebo, Outcome 6 Change in x-ray score.
[Analysis 1.7]
Analysis 1.7. Comparison 1 Mycobacterium vaccae immunotherapy versus placebo, Outcome 7 Erythrocyte sedimentation rate (mm/h) at completion of chemotherapy.
[Analysis 1.8]
Analysis 1.8. Comparison 1 Mycobacterium vaccae immunotherapy versus placebo, Outcome 8 Weight change (kg).
[Analysis 1.9]
Analysis 1.9. Comparison 1 Mycobacterium vaccae immunotherapy versus placebo, Outcome 9 Weight (kg) at completion of chemotherapy.
[Analysis 1.10]
Analysis 1.10. Comparison 1 Mycobacterium vaccae immunotherapy versus placebo, Outcome 10 Tuberculin skin test reaction: mean size (mm).
[Analysis 1.11]
Analysis 1.11. Comparison 1 Mycobacterium vaccae immunotherapy versus placebo, Outcome 11 Number requiring retreatment.
[Analysis 1.12]
Analysis 1.12. Comparison 1 Mycobacterium vaccae immunotherapy versus placebo, Outcome 12 Adverse events (local).
[Analysis 1.13]
Analysis 1.13. Comparison 1 Mycobacterium vaccae immunotherapy versus placebo, Outcome 13 Adverse events (any systemic).